This led the FDA to remove acceptance in June 2023. Supplemental warnings include the pitfalls linked to cholestatic hepatitis, hypercalcemia in people with breast most cancers, and greater danger for the development of prostatic hypertrophy and prostatic carcinoma in more mature individuals.[ten]Changes in weight come about with huge Life-style al